211 related articles for article (PubMed ID: 32298479)
1. In vitro synergy of eugenol on the antifungal effects of voriconazole against Candida tropicalis and Candida krusei strains isolated from the genital tract of mares.
Sharifzadeh A; Shokri H
Equine Vet J; 2021 Jan; 53(1):94-101. PubMed ID: 32298479
[TBL] [Abstract][Full Text] [Related]
2. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
3. Interaction of carvacroland voriconazole against drug - resistant Candida strains isolated from patients with candidiasis.
Sharifzadeh A; Shokri H; Abbaszadeh S
J Mycol Med; 2019 Apr; 29(1):44-48. PubMed ID: 30554935
[TBL] [Abstract][Full Text] [Related]
4. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
Drago M; Scaltrito MM; Morace G;
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
[TBL] [Abstract][Full Text] [Related]
6. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution.
Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2011 Feb; 49(2):630-7. PubMed ID: 21159940
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility of clinically isolated invasive
Wan FF; Zhang M; Guo J; Wu WJ
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1542-1549. PubMed ID: 37859369
[No Abstract] [Full Text] [Related]
9. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
[TBL] [Abstract][Full Text] [Related]
11. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Pfaller MA; Diekema DJ; Gibbs DL; Newell VA; Nagy E; Dobiasova S; Rinaldi M; Barton R; Veselov A;
J Clin Microbiol; 2008 Feb; 46(2):515-21. PubMed ID: 18077633
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole efficacy against Candida glabrata and Candida krusei: preclinical data using a validated in vitro pharmacokinetic/pharmacodynamic model.
Beredaki MI; Georgiou PC; Siopi M; Kanioura L; Arendrup MC; Mouton JW; Meletiadis J
J Antimicrob Chemother; 2020 Jan; 75(1):140-148. PubMed ID: 31665417
[TBL] [Abstract][Full Text] [Related]
13. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
14. Potential fungicidal effect of voriconazole against Candida spp.
Rubio MC; de Ocáriz IR; Gil J; Benito R; Rezusta A
Int J Antimicrob Agents; 2005 Mar; 25(3):264-7. PubMed ID: 15737524
[TBL] [Abstract][Full Text] [Related]
15. Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens.
Pfaller MA; Messer SA; Georgopapadakou N; Martell LA; Besterman JM; Diekema DJ
J Clin Microbiol; 2009 Dec; 47(12):3797-804. PubMed ID: 19794038
[TBL] [Abstract][Full Text] [Related]
16. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac exhibits synergism with azoles against planktonic cells and biofilms of
Brilhante RSN; Brasil JA; Oliveira JS; Pereira VS; Pereira-Neto WA; Sidrim JJC; Rocha MFG
Biofouling; 2020 May; 36(5):528-536. PubMed ID: 32546021
[TBL] [Abstract][Full Text] [Related]
18. Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Switzerland.
Orasch C; Marchetti O; Garbino J; Schrenzel J; Zimmerli S; Mühlethaler K; Pfyffer G; Ruef C; Fehr J; Zbinden R; Calandra T; Bille J;
Clin Microbiol Infect; 2014 Jul; 20(7):698-705. PubMed ID: 24188136
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing with the 24-hour CLSI BMD method for testing susceptibility of Candida species to fluconazole, posaconazole, and voriconazole by use of epidemiological cutoff values.
Pfaller MA; Espinel-Ingroff A; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
J Clin Microbiol; 2011 Mar; 49(3):845-50. PubMed ID: 21227994
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of antifungal activity of standardized extract of Salvia rhytidea Benth. (Lamiaceae) against various Candida isolates.
Salari S; Bakhshi T; Sharififar F; Naseri A; Ghasemi Nejad Almani P
J Mycol Med; 2016 Dec; 26(4):323-330. PubMed ID: 27499461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
